Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Shiro Fujii
TAK1 Is a Pivotal Therapeutic Target for Tumor Progression and Bone Destruction in Myeloma
Haematologica
Hematology
Related publications
Bone Destruction in Multiple Myeloma
Annals of the New York Academy of Sciences
Genetics
Molecular Biology
Biochemistry
Neuroscience
History
Philosophy of Science
FOXM1 Is a Therapeutic Target in High-Risk Multiple Myeloma
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
RSK2Ser227 at N-Terminal Kinase Domain Is a Potential Therapeutic Target for Multiple Myeloma
Molecular Cancer Therapeutics
Cancer Research
Oncology
TRAF6 Activation in Multiple Myeloma: A Potential Therapeutic Target
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
YAP1 Is Essential for Tumor Growth and Is a Potential Therapeutic Target for EGFR-dependent Lung Adenocarcinomas
Oncotarget
Oncology
Melanoma Inhibitor of Apoptosis Protein (ML-IAP) Is a Target for Immune-Mediated Tumor Destruction
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
TREM-1; Is It a Pivotal Target for Cardiovascular Diseases?
Bidirectional Notch Signaling and Osteocyte-Derived Factors in the Bone Marrow Microenvironment Promote Tumor Cell Proliferation and Bone Destruction in Multiple Myeloma
Cancer Research
Cancer Research
Oncology
EZH2 as a Therapeutic Target for Multiple Myeloma and Other Haematological Malignancies
Biomarker Research
Biochemistry
Molecular Medicine
Clinical Biochemistry
